Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study for Comparison of Reduced Intensity Conditioning Protocols Containing Either Thymoglobuline or Alemtuzumab in Patients Undergoing Allogeneic Transplant From Voluntary Unrelated Donors

NCT00354120 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.

NCT NCT00354120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study for Comparison of Reduced Intensity Conditioning Protocols Containing Either Thymoglobuline or Alemtuzumab in Patients Undergoing Allogeneic Transplant From Voluntary Unrelated Donors
Lead sponsor
Gruppo Italiano Trapianto di Midollo Osseo
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2005
Completion date
August 31, 2011
Enrollment
121 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloblastic leukemia, chronic myeloid leukemia, lympho-proliferative diseases, lymphoblastic leukemia, myelodysplasia, myelofibrosis